Form 8-K - Current report:
SEC Accession No. 0001444380-25-000021
Filing Date
2025-03-04
Accepted
2025-03-04 16:17:08
Documents
15
Period of Report
2025-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvro-20250304.htm   iXBRL 8-K 29084
2 EX-99.1 nvro-20250304xex99x1.htm EX-99.1 168118
6 img258922048_0a.jpg GRAPHIC 3333
  Complete submission text file 0001444380-25-000021.txt   342308

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvro-20250304.xsd EX-101.SCH 1789
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvro-20250304_lab.xml EX-101.LAB 21885
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvro-20250304_pre.xml EX-101.PRE 12516
17 EXTRACTED XBRL INSTANCE DOCUMENT nvro-20250304_htm.xml XML 2706
Mailing Address 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 1800 BRIDGE PARKWAY REDWOOD CITY CA 94065 650-251-0005
NEVRO CORP (Filer) CIK: 0001444380 (see all company filings)

EIN.: 562568057 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36715 | Film No.: 25704685
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)